✦ LIBER ✦
The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’11Iressa’ is a trademark of the AstraZeneca group of companies.) is not related to the expression of EGFR or HER-2 or to K-ras gene status
✍ Scribed by Suzuki, Takeshi; Nakagawa, Taku; Endo, Hideki; Mitsudomi, Tetsuya; Masuda, Akira; Yatabe, Yasushi; Sugiura, Takahiko; Takahashi, Takashi; Hida, Toyoaki
- Book ID
- 118571195
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 297 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.